Lexeo Therapeutics
Highly Engaged Employees
Chemicals & Related Products · New York, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
345 Park Ave S Fl 6, New York, New York,...Phone Number
(212) 547-9879Website
www.lexeotx.comRevenue
-Stock Symbol
LXEOIndustry
About Lexeo Therapeutics
Lexeo Therapeutics Org Chart
Is Lexeo Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Lexeo Therapeutics has new funding data
Product Launch: Get notified when Lexeo Therapeutics launches new products
Lexeo Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Lexeo Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Lexeo Therapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Lexeo Therapeutics
Check out if Lexeo Therapeutics is spiking on competitors!
Check if Lexeo Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Lexeo Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Lexeo Therapeutics
Compare insights from companies similar to Lexeo Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Lexeo Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Lexeo Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Lexeo Therapeutics.
Lexeo Therapeutics financials insights
Gather financial insights about Lexeo Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$85M
Series B
$100M
Stock Offering
$100M
Share Placement
$95M
Stock/Share Issuance
$80M
Lexeo Therapeutics Tech Stack
A closer look at the technologies used by Lexeo Therapeutics
Most Recent Scoops
Lexeo Therapeutics News & Media
Lexeo Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum
Lexeo Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic ForumLexeo Therapeutics, Inc. (LXEO) M&A Call Transcript
Lexeo Therapeutics, Inc. (LXEO) M&A Call September 22, 2026 8:00 AM EDTCompany ParticipantsAshley Kaplowitz - Head of Capital MarketsR.Lexeo Therapeutics Enters Into Agreement to Acquire Mantle Therapeutics and Announces Multiple New Strategic Collaborations to Expand Leadership in Friedreich Ataxia
Lexeo Therapeutics Enters Into Agreement to Acquire Mantle Therapeutics and Announces Multiple New Strategic Collaborations to Expand Leadership in FALexeo Therapeutics to Participate in Upcoming Investor Conferences in September
Lexeo Therapeutics to Participate in Upcoming Investor Conferences in September
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Lexeo Therapeutics
Based out of New York City, NY, Lexeo Therapeutics is a biotechnology company with a focus on genetic medicines and rare diseases. Lexeo is a clinical stage genetic medicine company dedicated to reshaping heart health by applying pioneering science to fundamentally change how cardiovascular diseases are treated.... Read More
